GEA invests EUR 80 million in a pharmaceutical technology center for freeze-drying systems in Germany

First product chambers in the “Factory of the Future”

28-Jul-2025 - GEA is investing EUR 80 million in the construction of a pharmaceutical technology center for freeze-drying systems in Elsdorf (North Rhine-Westphalia). Partial approval was granted by the authorities in July 2025. With the new location, GEA is responding to the growing global demand for ...

Successful closing: Syntegon and Telstar officially join forces

05-Nov-2024 - Following regulatory approval, Syntegon and Azbil Corporation have officially closed the acquisition of Telstar by Syntegon. The Telstar workforce will now join the Syntegon team in the Pharma Liquid Business Unit. With the joint offering of fill-finish equipment, isolator systems, freeze-dryers, ...

Christ acquires manufacturer of loading and monitoring systems

24-Oct-2022 - Motus Engineering GmbH & Co. KG, a manufacturer of loading and unloading systems, will belong to Martin Christ Gefriertrocknungsanlagen GmbH effectiveJanuary1, 2023. Strategic cooperation between the two companies has been in place for several years and will be further intensified by the ...

Genevac Consolidate Evaporator & Freeze Dryer Operations In Germany

17-Apr-2015 - Genevac has announced, as of 1st April 2015, that LMS Consult GmbH (LMS) has been appointed as the exclusive German distributor for its market leading evaporator systems plus the freeze dryer range of its parent company - SP Scientific.For over 30 years - LMS Consulthave successfully sold and ...

Vetter Invests in Additional Lyophilization Capacity

17-Jun-2011 - Vetter has installed three additional state-of-the-art lyophilizers at the company’s Ravensburg Vetter South facility, nearly doubling its number of freeze-dryers. Altogether, the site will be able to produce up to 24 million lyophilized units annually. The new equipment increases the number of ...

Chinese Skystar Bio-Pharmaceutical Develops Over 20 New Microorganism Products

$550,000 annual revenue expected

12-Jul-2007 - Skystar Bio-Pharmaceutical Co., Ltd. has successfully developed over 20 new products for livestock and aquatic animals with the drug-resistant microorganism lactobacillus acidophilus ("L. acidophilus"). The launch of these new products is expected to add over $550,000 to the company's ...